Year: 2021

GENEVA, Switzerland, Dec. 20, 2021 (GLOBE NEWSWIRE) — In accordance with Nasdaq Stockholm AB’s decision, following application from the board of directors of Etrion Corporation (“Etrion” or the “Company”) (OMX: ETX), the common shares of Etrion Corporation will be delisted from Nasdaq Stockholm. The last day of trading is on 4 January 2022. About Etrion The Company is listed on the Nasdaq Stockholm exchange in Sweden under ticker symbol “ETX”. Etrion’s largest shareholder is the Lundin family, which owns approximately 36% of the Company’s shares directly and through various trusts. For additional information, please visit the Company’s website at www.etrion.com or contact: Christian Lacueva – Chief Financial Officer Telephone: +41 22 715 20 90    The information was submitted for publication at 08.05 CET on December 20, 2021.

Scanfil plc Stock Exchange Release 20 December 2021 8.00 a.m. CET Scanfil strengthens its Group Management Team and recruits Christina Wiklund as a Chief Commercial Officer Christina Wiklund has been appointed as the Chief Commercial Officer starting 17 January 2022. Christina comes from GE Additive, part of General Electric Company, where she held the Vice President/Head of Sales EMEA position. She has more than 20 years of experience in electronics manufacturing and sales. Before joining GE Additive, she worked at Flex, a global manufacturing & supply chain company, where she was Vice President of sales and account management. Before Flex, Christina worked at Solectron and Ericsson in business development and account management roles. “I’m very happy that we are getting Christina to our team. With her experience,...

SKISTAR OPENS THE WINTER SEASON WITH RECORD-HIGH BOOKINGS – BILLION INVESTMENTS IN THE MOUNTAIN RESORTS OF THE FUTURE First QuarterNet sales for the first quarter were SEK 155 (154) million, an increase of SEK 1 million (1 percent) compared with the previous year. Profit after tax was SEK -315 (-251) million, a decline of SEK 64 million (25 percent) compared with the previous year. Earnings per share amounted to SEK -3.97 (-3.12).Significant events after the end of the periodSkiStar strengthens its position as the leading tour operator for Scandinavia and increases its investment rate; firstly, by investing in two new ski lifts in Åre and in a year-round investment in Hammarbybacken in Stockholm with an expansion of the offer for the guests. As of December 3, all of SkiStar’s Swedish and Norwegian destinations were open with...

Ad hoc announcement pursuant to Art. 53 LRLigelizumab, a high-affinity anti-IgE antibody, demonstrated superiority compared with placebo at Week 12 in Phase III PEARL 1 and PEARL 2 trials, but not versus omalizumab1Novartis is continuing to evaluate the PEARL data and will provide an update in due course as well as next steps for the programBasel, December 20, 2021 – Novartis today announced top-line results from PEARL 1 and PEARL 2 Phase III studies in chronic spontaneous urticaria (CSU), which showed that the studies met their primary endpoints of superiority for ligelizumab versus placebo at Week 12, but not versus omalizumab1. “We are disappointed that we have been unable to demonstrate superior efficacy for ligelizumab versus standard of care in the treatment of CSU,” said John Tsai, M.D., Head of Global Drug Development and...

In 2022 AS Merko Ehitus will publish its consolidated financial results according to the schedule below:Date            Event10 February 2022 2021 12 months and 4th quarter unaudited interim report7 April 2022 Audited Annual Report 20215 May 2022 2022 3 months unaudited interim report4 August 2022 2022 6 months and 2nd quarter unaudited interim report3 November 2022 2022 9 months and 3rd quarter unaudited interim reportThe annual general meeting of shareholders for 2021 financial year will take place in the second quarter of 2022. Exact time and location will be confirmed accordingly. Urmas SomelarFinantsüksuse juhtAS Merko EhitusTelefon: +372 650 1250E-post: urmas.somelar@merko.ee AS Merko Ehitus (group.merko.ee) group consists of AS Merko Ehitus Eesti in Estonia, SIA Merks in Latvia, UAB Merko...

GENEVA, Switzerland December 20, 2021 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective as of market open on Monday, December 20, 2021. “We are proud to be included in the prestigious Nasdaq Biotechnology Index,” said Brian O’Callaghan, CEO of ObsEva. “Over the last year, we have made numerous achievements across all areas of the business, with significant progress against our clinical and regulatory milestones. Being part of this index enables us to reach new audiences and I look forward to this exciting next chapter as we continue to grow, bring innovation to the field of women’s health and build on our success to date.” The...

20 December 2021, 7:00am, Antwerp, Belgium: VGP NV (‘VGP’ or the ‘Group’), a European provider of high-quality logistics and semi-industrial real estate, announces that it has recently acquired two properties in Southern Germany. The first project is located in Wiesloch/Walldorf, where VGP is developing together with Heidelberger Druckmaschinen AG (‘Heidelberg’) a modern, so-called “HEI-TECH” industrial park. In this context, the Group has acquired a further 80,000 m2 of land from Heidelberg. A corresponding purchase agreement was signed by both companies. Together with the approximately 130,000 m2 already acquired in 2020, VGP anticipates developing an innovative, urbanistically sophisticated office and technology quarter in the Rhine-Neckar metropolitan region in close cooperation with Heidelberg. The first construction measures to redevelop...